TrialMedicine2020

Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study.

Ayumu Hosokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.